Generally, it has been observed that women are older than men at hospitalization for myocardial infarction (MI), and also present less frequently with chest pain/discomfort. Howeve [more...]
While it is suggested that short-term exposure to high levels of air pollution may trigger myocardial infarction (MI), the association remains unclear. Backed by the idea, Mustafic [more...]
Paller and colleagues in a recent review published in the journal of Chemical Immunology and Allergy discussed latest approaches in the treatment of atopic dermatitis (AD). Accordi [more...]
A recent study investigated the efficacy of non-invasive knee ultrasonography (US) in detecting degenerative changes of articular cartilage. Forty adult patients with knee pain who [more...]
Both patient and lesion factors make percutaneous coronary intervention (PCI) for protected left main coronary artery (PLM) disease a complex issue. This warrants further cautious [more...]
Currently different molecular techniques are available for the diagnosis of dermatophytosis. Molecular diagnosis of dermatophytosis relate to the direct detection of dermatophyte D [more...]

Click here to view more news
 
 
 
Diploma Program
Dyslipidemia
Dyslipidemia, defined as derangement of lipoproteins in the body, is one of the most common disorders prevalent around the world. Patients with dyslipidemia are usually asymptomatic initially and therefore difficult to be diagnosed clinically. Its association with cardiovascular diseases (CVD) cannot be overemphasized. A knowledge of the types of lipoproteins in the body, their role in lipid transport, forms of dyslipidemia and the recommended time intervals to assess lipid profile (particularly in asymptomatic individuals) is essential for the clinicians. Diploma program on dyslipidemia is an academic program which has been designed to address different ssues concerned with dyslipidemia existing in a GPs mind; the course aims to update them with information related to lipoproteins, their role in lipid transport, their abnormalities and its pertinent health impact. The program incorporates questions which are for the participants to self evaluate and decide how well they have understood the course contents.
Diploma Program
Atherosclerosis
Atherosclerosis is a widely prevalent disease around the world. This systemic disease usually affects most blood vessels in the body, with significant clinical manifestations arising from its development in the coronary, cerebral, and lower extremity circulation. Although the exact mechanism of its development still needs to be elucidated completely, extensive work done by investigators over the past few decades has indicated that this disease is primarily an inflammatory process which results in the formation of an atherosclerotic plaque inside the blood vessels; rupture of an unstable plaque and subsequent thrombosis predisposes to fatal coronary and cerebrovascular events. This diploma program aims to update clinicians (cardiologists) on recent reports related to risk factors and pathophysiology of atherosclerosis and strategies for the diagnosis of subclinical atherosclerosis in asymptomatic individuals.
Diploma Program
ACID PEPTIC DISORDERS & IBS
Wide influxes of patients with overlapping gastric complaints identify gastroenterology as one complex medical domain with distinct indistinctness. Patients frequently present with multiple non-specific symptoms, and put the attending clinician in a dilemma concerning their cause, i.e., if the symptoms are because of an underlying “organic cause” or “functional” in origin. This diploma program is an attempt to update clinicians regarding two characteristic gastrointestinal presentations: “Acid peptic disorders”, which include gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD) in particular; and the “Irritable bowel syndrome (IBS )”. The idea is that clinicians be more confident while approaching patients with these gastric disorders.
H.Pylori Infections
H.Pylori Infections
H.Pylori Infections
Clinical Workshop on Acid Peptic Disorders
Clinical Workshop on Acid Peptic Disorders
Clinical Workshop on Acid Peptic Disorders
Hepatobiliary Disorders
Cholestasis
The liver is a complex organ associated with multiple functions. One of the important functions of the liver is formation and secretion of bile.
Dermatology Review
Alopecia in Women
Hair loss is a natural phenomenon which normally occurs during the hair growth cycle in all the humans. But excessive or abnormal hair loss due to the increase in shedding of hair, either diffused or localized, results in alopecia (baldness).
Cardiology Update
Heart Failure and its Management
Heart failure is a condition where the heart is unable to maintain an adequate cardiac output to meet the metabolic demands, and/or it is trying to maintain it from an abnormally elevated filling pressure.
 
19th WONCA Asia Pacific Regional Conference
Date : 24 – 27 May, 2012
Venue : Jeju, Korea (south)
Website : http://www.woncaap2012.org
 
World Stem Cells & Regenerative Medicine Congress 2012
Date : 21st to 23rd May 2012
Venue : London, United Kingdom
Website : http://www.terrapinn.com/2012/stemcells/
 
The 6th International Conference on Bioinformatics and Biomedical Engineering (iCBBE2012)
Date : 17 – 20 May, 2012
Venue : Shanghai, China
Website : http://www.icbbe.org/2012
 
2nd Global Conference: The Patient
Date : 16 – 18 May, 2012
Venue : Prague, Czech Republic
Website : http://www.inter-disciplinary.net/probing-the-boundaries/persons/the-patient/call-for-papers/
 
The International Conference on Integrative Medicine
Date : 13 – 15 May, 2012
Venue : Jerusalem, Israel
Website : http://www.mediconvention.com
 
7th International Conference on Rapid Response Systems and Medical Emergency Teams
Date : 7 – 9 May, 2012
Venue : Sydney, New South Wales, Australia
Website : http://www.rapidresponsesystems.org/
 
 
Higher risk of venous thromboembolism related to the use of non-oral hormonal contraceptives than oral hormonal contraceptives
Discovery of different mechanisms of pain suggest new strategies for drug development
Higher beta-blocker dose associated with lower mortality in heart failure patients